{"meshTagsMajor":["Drug Resistance, Neoplasm"],"meshTags":["Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Breast Neoplasms","Drug Resistance, Neoplasm","Enzyme Activation","Female","Humans","Mutation","PTEN Phosphohydrolase","Phosphatidylinositol 3-Kinases","Phosphoric Monoester Hydrolases","Receptor, ErbB-2","Signal Transduction","Trastuzumab","Tumor Suppressor Proteins"],"meshMinor":["Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Breast Neoplasms","Enzyme Activation","Female","Humans","Mutation","PTEN Phosphohydrolase","Phosphatidylinositol 3-Kinases","Phosphoric Monoester Hydrolases","Receptor, ErbB-2","Signal Transduction","Trastuzumab","Tumor Suppressor Proteins"],"genes":["PTEN"],"publicationTypes":["Journal Article"],"title":"Breast cancer--loss of PTEN predicts resistance to treatment.","pubmedId":"15564551"}